SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiation

This publication has 16 references indexed in Scilit:

• A Specific Antagonist of the p110δ Catalytic Component of Phosphatidylinositol 3′-Kinase, IC486068, Enhances Radiation-Induced Tumor Vascular Destruction
  Cancer Research, 2004
• Src Family Protein-tyrosine Kinases Alter the Function of PTEN to Regulate Phosphatidylinositol 3-Kinase/AKT Cascades
  Journal of Biological Chemistry, 2003
• Src and phosphatidylinositol 3–kinase mediate soluble E-selectin–induced angiogenesis
  Blood, 2003
• The hunting of the Src
  Nature Reviews Molecular Cell Biology, 2001
• SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling
  Molecular and Cellular Biology, 2000
• Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?
  Trends in Pharmacological Sciences, 2000
• New Roles for Src Kinases in Control of Cell Survival and Angiogenesis
  Cell, 2000
• Selective Requirement for Src Kinases during VEGF-Induced Angiogenesis and Vascular Permeability
  Molecular Cell, 1999
• AKT/PKB and Other D3 Phosphoinositide-Regulated Kinases: Kinase Activation by Phosphoinositide-Dependent Phosphorylation
  Annual Review of Biochemistry, 1999
• CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
  Annual Review of Cell and Developmental Biology, 1997